Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21(ras) and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells

Molecular Endocrinology

Volumn 13, Issue 9, 1999, Pages 1615-1626

  Gendron, Louis ^a   Laflamme, Liette ^a   Rivard, Nathalie ^a   Asselin, Claude ^a   Payet, Marcel D ^a   Gallo Payet, Nicole ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; CYTOPLASM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; TUBULIN; TYROSINE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ENZYME INHIBITOR; FLAVONOID; PHOSPHOPROTEIN; PHOSPHOTYROSINE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOBLOTTING; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NEURITE; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA;

ANGIOTENSIN II; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION; MUTATION; NEURITES; NEURONS; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033237655     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.9.0344     Document Type: Article

References (75)

1. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: A functional neuroanatomical review
2. Angiotensin receptors and their therapeutic implications
3. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells
4. 2 is present throughout the human fetal adrenal gland of the second trimester gestation
5. Early expression of all the components of the renin-angiotensin-system in human development
6. 2 angiotensin II receptor subtypes in the rat brain during development
7. Angiotensin-II receptor subtypes in fetal tissues of the rat: Autoradiography, guanine nucleotide sensitivity and association with phosphoinositide hydrolysis
8. Molecular characterization of angiotensin II type 2 receptors in rat pheochromocytoma cells
9. 2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells
10. 2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors
11. 2 receptors in the developing rat fetus
12. 2) receptor in R3T3 cells
13. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase
14. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
15. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure
16. 2 and muscarinic receptor blockade on osmotically induced vasopressin release
17. 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
18. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
19. 2 angiotensin receptors to its cognitive effects
20. 2 receptor inhibits proliferation and promotes differentiation in PC12W cells
21. Angiotensin II type 2 receptor mediates programmed cell death
22. Angiotensin receptors
23. The role of angiotensin receptors in cardiovascular diseases
24. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition
25. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors
26. 2 receptors do not interact with guanine nucleotide binding proteins
27. 2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells
28. Angiotensin II receptor subtypes: Characterization, signaling mechanisms, and possible physiological implications
29. + currents involves an inhibitory GTP binding protein
30. Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism
31. 2) binding sites in R3T3 cells
32. 2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase
33. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain
34. 2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats
35. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats
36. 2
37. 2 receptor down-regulates neurofilament M in PC12W cells
38. Mammalian MAP kinase modules: How to transduce specific signals
39. A synthetic inhibitor of the mitogen-activated protein kinase cascade
40. Nerve growth factor-stimulated mitogen activated kinase activity is not necessary for neurite outgrowth of chick dorsal root ganglion sensory and sympathetic neurons
41. Activation of mitogen-activated protein kinases is not required for the extension of neurites from PC12D cells triggered by nerve growth factor
42. Isolation of a subclonal cell line of PC12 transfected with dexamethasone-regulated ras oncogene: Morphological differentiation, biochemical properties and tumorigenicity
43. Effect of a dorainant inhibitory Ha-Ras mutation on neuronal differentiation of PC12 cells
44. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
45. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
46. cAMP activates MAP kinase and Elk-1 through a B-Raf-and Rap1 -dependent pathway
47. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor
48. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral
49. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor
50. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling
51. Culture and characteristics of hormone-responsive neuroblastoma X glioma hybrid cells
52. Distinct mode of microtubule-associated proteins expression in the neuroblastoma, glioma cell line 108CC15/NG108-15
53. Activity of Rap1 is regulated by bombesin, cell adhesion, and cell density in NIH3T3 fibroblasts
54. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells
55. 2 receptors: Evidence for selective sorting of receptor and ligand
56. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
57. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
58. Nitric oxide triggers a switch to growth arrest during differentiation of neural cells
59. Angiotensin II signalling events mediated by tyrosine phosphorylation
60. Angiotensin II controls p21(ras) activity via pp60(c-src)
61. Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: Cross-talk between phosphoinositides, adenosine 3', 5'-monophosphate, and tyrosine kinase receptor pathways
62. Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells
63. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells
64. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf
65. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism
66. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
67. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG 108-115 cells
68. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells
69. Multiple cyclic nucleotide phosphodiesterase
70. Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains
71. Accumulation of p21(ras)-GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity
72. Quantitative analysis of the complex between p21Ras and the Ras-binding domain of the human Raf-1 protein kinase
73. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
74. Transforming p21(ras) mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
75. Regulation of CCAAT/enhancer binding protein isoforms by serum and glucocorticoids in the rat intestinal epithelial crypt cell line IEC-6